Laboratory-monitored fondaparinux and coagulation activity in association with total hip replacement.
2014
Fondaparinux, indirect factor Xa (FXa) inhibitor, is recommended for thromboprophylaxis for high-risk patients undergoing major orthopedic surgery. We evaluated the prothrombotic state and anticoagulant intensity of fondaparinux (2.5 mg daily) after total hip replacement (THR). Twenty patients under
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
17
References
3
Citations
NaN
KQI